347 related articles for article (PubMed ID: 25466928)
1. Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
Salih MA; Fakiola M; Abdelraheem MH; Younis BM; Musa AM; ElHassan AM; Blackwell JM; Ibrahim ME; Mohamed HS
BMC Infect Dis; 2014 Dec; 14():662. PubMed ID: 25466928
[TBL] [Abstract][Full Text] [Related]
2. IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan.
Salih MA; Ibrahim ME; Blackwell JM; Miller EN; Khalil EA; ElHassan AM; Musa AM; Mohamed HS
Genes Immun; 2007 Jan; 8(1):75-8. PubMed ID: 17136124
[TBL] [Abstract][Full Text] [Related]
3. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.
Ansari NA; Ramesh V; Salotra P
J Infect Dis; 2006 Oct; 194(7):958-65. PubMed ID: 16960784
[TBL] [Abstract][Full Text] [Related]
4. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.
Mohamed HS; Ibrahim ME; Miller EN; Peacock CS; Khalil EA; Cordell HJ; Howson JM; El Hassan AM; Bereir RE; Blackwell JM
Genes Immun; 2003 Jul; 4(5):351-5. PubMed ID: 12847550
[TBL] [Abstract][Full Text] [Related]
6. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.
Zijlstra EE; el-Hassan AM; Ismael A
Am J Trop Med Hyg; 1995 Apr; 52(4):299-305. PubMed ID: 7741164
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population.
Farouk S; Salih MA; Musa AM; Blackwell JM; Miller EN; Khalil EA; Elhassan AM; Ibrahim ME; Mohamed HS
Public Health Genomics; 2010; 13(6):362-7. PubMed ID: 20051670
[TBL] [Abstract][Full Text] [Related]
8. Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S59-76. PubMed ID: 11370251
[TBL] [Abstract][Full Text] [Related]
9. Leishmaniasis in Sudan. Visceral leishmaniasis.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
[TBL] [Abstract][Full Text] [Related]
10. Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S; Das NK; Barbhuiya JN; Chatterjee M
Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917
[TBL] [Abstract][Full Text] [Related]
11. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
Zijlstra EE
Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
[TBL] [Abstract][Full Text] [Related]
12. Post-kala-azar dermal leishmaniasis.
Zijlstra EE; Musa AM; Khalil EA; el-Hassan IM; el-Hassan AM
Lancet Infect Dis; 2003 Feb; 3(2):87-98. PubMed ID: 12560194
[TBL] [Abstract][Full Text] [Related]
13. Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states.
Saurabh S; Roy P; Pandey DK; Ray D; Tarak S; Pandey R; Kumar D; Jamil S; Paulraj A; Kumar A; Dutta S
J Vector Borne Dis; 2020; 57(2):161-169. PubMed ID: 34290161
[TBL] [Abstract][Full Text] [Related]
14. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
[No Abstract] [Full Text] [Related]
15. Evaluation of blood based quantitative PCR as a molecular diagnostic tool for post kala-azar dermal leishmaniasis (PKDL).
Kumar A; Singh VK; Madhukar P; Tiwari R; Roy R; Rajneesh ; Mehrotra S; Sundar S; Kumar R
Mol Biol Rep; 2024 Jun; 51(1):716. PubMed ID: 38824237
[TBL] [Abstract][Full Text] [Related]
16. Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.
Mukherjee S; Mukhopadhyay D; Braun C; Barbhuiya JN; Das NK; Chatterjee U; von Stebut E; Chatterjee M
Exp Dermatol; 2015 Mar; 24(3):232-4. PubMed ID: 25580856
[TBL] [Abstract][Full Text] [Related]
17. Reliable diagnosis of post-kala-azar dermal leishmaniasis (PKDL) using slit aspirate specimen to avoid invasive sampling procedures.
Verma S; Bhandari V; Avishek K; Ramesh V; Salotra P
Trop Med Int Health; 2013 Mar; 18(3):268-75. PubMed ID: 23279800
[TBL] [Abstract][Full Text] [Related]
18. Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis.
Osman OF; Oskam L; Kroon NC; Schoone GJ; Khalil ET; El-Hassan AM; Zijlstra EE; Kager PA
J Clin Microbiol; 1998 Jun; 36(6):1621-4. PubMed ID: 9620389
[TBL] [Abstract][Full Text] [Related]
19. Post kala azar dermal leishmaniasis in Sudan.
Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
[TBL] [Abstract][Full Text] [Related]
20. High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis.
Gasim S; Theander TG; ElHassan AM
Acta Trop; 2000 Feb; 75(1):35-8. PubMed ID: 10708005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
